Brigati JR, Petrenko VA Thermostability of landscape phage probes. Anal Bioanal Chem. 2005 Jul;382(6):1346-50. Epub 2005 Jun 18.
Davis MI, Bennett MJ, Thomas LM, Bjorkman PJ Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):5981-6. Epub 2005 Apr 18.
Diaz JE, Yang LM, Lamboy JA, Penner RM, Weiss GA Synthesis of a virus electrode for measurement of prostate specific membrane antigen. Methods Mol Biol. 2009;504:255-74. doi: 10.1007/978-1-60327-569-9_16.
Donavan KC, Arter JA, Weiss GA, Penner RM Virus-poly(3,4-ethylenedioxythiophene) biocomposite films. Langmuir. 2012 Aug 28;28(34):12581-7. doi: 10.1021/la302473j. Epub 2012 Aug 16.
Ellington AD, Szostak JW In vitro selection of RNA molecules that bind specific ligands. Nature. 1990 Aug 30;346(6287):818-22.
Guan W, Duan X, Reed MA Highly specific and sensitive non-enzymatic determination of uric acid in serum and urine by extended gate field effect transistor sensors. Biosens Bioelectron. 2014 Jan 15;51:225-31. doi: 10.1016/j.bios.2013.07.061. Epub 2013 Aug 7.
Kay, B K. (1996) Table 15. M13 Stability and Instability, In Phage Display of Peptides and Proteins: A Laboratory Manual (Kay, B. K., Winter, J., McCafferty, J., Ed.), p 337, Academic Press, San Diego.
Levin AM, Coroneus JG, Cocco MJ, Weiss GA Exploring the interaction between the protein kinase A catalytic subunit and caveolin-1 scaffolding domain with shotgun scanning, oligomer complementation, NMR, and docking. Protein Sci. 2006 Mar;15(3):478-86. Epub 2006 Feb 1.
Levin AM, Weiss GA Optimizing the affinity and specificity of proteins with molecular display. Mol Biosyst. 2006 Jan;2(1):49-57. Epub 2005 Nov 8. Review.
Liu J, Cao Z, Lu Y Functional nucleic acid sensors. Chem Rev. 2009 May;109(5):1948-98. doi: 10.1021/cr030183i. Review.
Lunder, M , Bratkovic, T., Anderluh, G., Strukelj, B., and Kreft, S. (2008) Affinity ranking of phage-displayed peptides: Enzyme-linked immunosorbent assay versus surface plasmon resonance, Acta Chimica Slovenica 55, 233-235.
Majumdar S, Hajduczki A, Mendez AS, Weiss GA Phage display of functional, full-length human and viral membrane proteins. Bioorg Med Chem Lett. 2008 Nov 15;18(22):5937-40. doi: 10.1016/j.bmcl.2008.07.051. Epub 2008 Jul 17.
Mohan K, Donavan KC, Arter JA, Penner RM, Weiss GA Sub-nanomolar detection of prostate-specific membrane antigen in synthetic urine by synergistic, dual-ligand phage. J Am Chem Soc. 2013 May 22;135(20):7761-7. doi: 10.1021/ja4028082. Epub 2013 May 13.
Mohan K, Weiss GA Dual genetically encoded phage-displayed ligands. Anal Biochem. 2014 May 15;453:1-3. doi: 10.1016/j.ab.2014.02.025. Epub 2014 Mar 4.
Nutiu R, Li Y In vitro selection of structure-switching signaling aptamers. Angew Chem Int Ed Engl. 2005 Feb 4;44(7):1061-1065. doi: 10.1002/anie.200461848.
Oh SS, Plakos K, Lou X, Xiao Y, Soh HT In vitro selection of structure-switching, self-reporting aptamers. Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14053-8. doi: 10.1073/pnas.1009172107. Epub 2010 Jul 26.
Toma M, Loget G, Corn RM Flexible Teflon nanocone array surfaces with tunable superhydrophobicity for self-cleaning and aqueous droplet patterning. ACS Appl Mater Interfaces. 2014 Jul 23;6(14):11110-7. doi: 10.1021/am500735v. Epub 2014 Apr 1.
Tuerk C, Gold L Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990 Aug 3;249(4968):505-10.
Wood JB, Szyndler MW, Halpern AR, Cho K, Corn RM Fabrication of DNA microarrays on polydopamine-modified gold thin films for SPR imaging measurements. Langmuir. 2013 Aug 27;29(34):10868-73. doi: 10.1021/la402425n. Epub 2013 Aug 15.
Yang LM, Diaz JE, McIntire TM, Weiss GA, Penner RM Direct electrical transduction of antibody binding to a covalent virus layer using electrochemical impedance. Anal Chem. 2008 Aug 1;80(15):5695-705. doi: 10.1021/ac8008109. Epub 2008 Jul 1.
Zhao W, Ali MM, Aguirre SD, Brook MA, Li Y Paper-based bioassays using gold nanoparticle colorimetric probes. Anal Chem. 2008 Nov 15;80(22):8431-7. doi: 10.1021/ac801008q. Epub 2008 Oct 11.
Electro-Phage and Colorimetric Aptamer Sensors for Clinical Staging and Monitoring of Bladder Cancer
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.